Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-13

FDA Approved: OXALIPLATIN — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved the supplemental application for Oxaliplatin from Eugia US LLC, granting regulatory approval of a generic oxaliplatin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

SUPPL AP for OXALIPLATIN (OXALIPLATIN)